Product Information
- 6-(2,4-Dichlorophenyl)-8-ethyl-2-[[3-fluoro-4-(1-piperazinyl)phenyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one
FRAX486 is a kinase inhibitor that binds to the ATP-binding site of the epidermal growth factor receptor (EGFR) and prevents it from binding to ATP. The EGFR is involved in signaling pathways that are important for cell proliferation, differentiation, and survival. FRAX486 is selective for EGFR over other members of the tyrosine kinase family, such as CDK4/6. This drug has been shown to inhibit tumor growth by inducing apoptosis in mutant melanoma cells and inhibiting their migration. It also inhibits the phosphorylation of actin filaments and reduces bladder inflammation.
Chemical properties
Technical inquiry about: 3D-HZB03035 FRAX486
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
